0 XP   0   0   0

Eris Lifesciences Ltd










Financial Health of Eris Lifesciences Ltd




Comparing to competitors in the Pharmaceuticals industry




  Industry Rankings  


Eris Lifesciences Ltd
Buy, Hold or Sell?

Should you buy, hold or sell Eris Lifesciences Ltd?

I guess you are interested in Eris Lifesciences Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Eris Lifesciences Ltd

Let's start. I'm going to help you getting a better view of Eris Lifesciences Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Eris Lifesciences Ltd even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Eris Lifesciences Ltd is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Eris Lifesciences Ltd. The closing price on 2022-12-06 was INR658.70 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Eris Lifesciences Ltd Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Eris Lifesciences Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Eris Lifesciences Ltd earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Eris Lifesciences Ltd to the Pharmaceuticals industry mean.
  • A Net Profit Margin of 26.1% means that ₹0.26 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Eris Lifesciences Ltd:

  • The MRQ is 26.1%. The company is making a huge profit. +2
  • The TTM is 26.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ26.1%TTM26.2%-0.1%
TTM26.2%YOY28.7%-2.5%
TTM26.2%5Y27.5%-1.3%
5Y27.5%10Y27.5%0.0%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ26.1%3.3%+22.8%
TTM26.2%6.9%+19.3%
YOY28.7%9.9%+18.8%
5Y27.5%6.3%+21.2%
10Y27.5%6.7%+20.8%
1.1.2. Return on Assets

Shows how efficient Eris Lifesciences Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Eris Lifesciences Ltd to the Pharmaceuticals industry mean.
  • 4.2% Return on Assets means that Eris Lifesciences Ltd generated ₹0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Eris Lifesciences Ltd:

  • The MRQ is 4.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.2%TTM3.9%+0.3%
TTM3.9%YOY4.7%-0.9%
TTM3.9%5Y4.3%-0.4%
5Y4.3%10Y4.3%0.0%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2%0.8%+3.4%
TTM3.9%1.3%+2.6%
YOY4.7%1.5%+3.2%
5Y4.3%1.4%+2.9%
10Y4.3%1.4%+2.9%
1.1.3. Return on Equity

Shows how efficient Eris Lifesciences Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Eris Lifesciences Ltd to the Pharmaceuticals industry mean.
  • 5.9% Return on Equity means Eris Lifesciences Ltd generated ₹0.06 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Eris Lifesciences Ltd:

  • The MRQ is 5.9%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 5.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.9%TTM5.1%+0.9%
TTM5.1%YOY5.6%-0.5%
TTM5.1%5Y5.3%-0.3%
5Y5.3%10Y5.3%0.0%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ5.9%1.5%+4.4%
TTM5.1%2.0%+3.1%
YOY5.6%3.0%+2.6%
5Y5.3%2.1%+3.2%
10Y5.3%2.0%+3.3%

1.2. Operating Efficiency of Eris Lifesciences Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Eris Lifesciences Ltd is operating .

  • Measures how much profit Eris Lifesciences Ltd makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Eris Lifesciences Ltd to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Eris Lifesciences Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ--5.6%+5.6%
TTM-0.5%-0.5%
YOY-6.2%-6.2%
5Y-5.1%-5.1%
10Y-5.2%-5.2%
1.2.2. Operating Ratio

Measures how efficient Eris Lifesciences Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 0.95 means that the operating costs are ₹0.95 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Eris Lifesciences Ltd:

  • The MRQ is 0.952. The company is less efficient in keeping operating costs low.
  • The TTM is 0.933. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.952TTM0.933+0.019
TTM0.933YOY0.519+0.414
TTM0.9335Y0.726+0.207
5Y0.72610Y0.7260.000
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9521.342-0.390
TTM0.9331.276-0.343
YOY0.5191.169-0.650
5Y0.7261.149-0.423
10Y0.7261.178-0.452

1.3. Liquidity of Eris Lifesciences Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Eris Lifesciences Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 1.71 means the company has ₹1.71 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Eris Lifesciences Ltd:

  • The MRQ is 1.710. The company is able to pay all its short-term debts. +1
  • The TTM is 2.426. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.710TTM2.426-0.716
TTM2.426YOY2.714-0.288
TTM2.4265Y2.570-0.144
5Y2.57010Y2.5700.000
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7102.205-0.495
TTM2.4262.010+0.416
YOY2.7142.125+0.589
5Y2.5701.812+0.758
10Y2.5701.786+0.784
1.3.2. Quick Ratio

Measures if Eris Lifesciences Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Eris Lifesciences Ltd to the Pharmaceuticals industry mean.
  • A Quick Ratio of 1.01 means the company can pay off ₹1.01 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Eris Lifesciences Ltd:

  • The MRQ is 1.015. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.875. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.015TTM1.875-0.860
TTM1.875YOY2.157-0.283
TTM1.8755Y2.016-0.141
5Y2.01610Y2.0160.000
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0151.118-0.103
TTM1.8751.152+0.723
YOY2.1571.091+1.066
5Y2.0161.007+1.009
10Y2.0160.869+1.147

1.4. Solvency of Eris Lifesciences Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Eris Lifesciences Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Eris Lifesciences Ltd to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.29 means that Eris Lifesciences Ltd assets are financed with 29.4% credit (debt) and the remaining percentage (100% - 29.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Eris Lifesciences Ltd:

  • The MRQ is 0.294. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.227. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.294TTM0.227+0.067
TTM0.227YOY0.150+0.077
TTM0.2275Y0.188+0.038
5Y0.18810Y0.1880.000
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2940.381-0.087
TTM0.2270.379-0.152
YOY0.1500.417-0.267
5Y0.1880.398-0.210
10Y0.1880.399-0.211
1.4.2. Debt to Equity Ratio

Measures if Eris Lifesciences Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Eris Lifesciences Ltd to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 41.6% means that company has ₹0.42 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Eris Lifesciences Ltd:

  • The MRQ is 0.416. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.303. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.416TTM0.303+0.112
TTM0.303YOY0.176+0.127
TTM0.3035Y0.240+0.063
5Y0.24010Y0.2400.000
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4160.586-0.170
TTM0.3030.598-0.295
YOY0.1760.598-0.422
5Y0.2400.671-0.431
10Y0.2400.664-0.424

2. Market Valuation of Eris Lifesciences Ltd

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Eris Lifesciences Ltd generates.

  • Above 15 is considered overpriced but always compare Eris Lifesciences Ltd to the Pharmaceuticals industry mean.
  • A PE ratio of 80.36 means the investor is paying ₹80.36 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Eris Lifesciences Ltd:

  • The EOD is 74.459. Neutral. Compare to industry.
  • The MRQ is 80.360. Neutral. Compare to industry.
  • The TTM is 98.507. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD74.459MRQ80.360-5.901
MRQ80.360TTM98.507-18.148
TTM98.507YOY43.639+54.868
TTM98.5075Y71.073+27.434
5Y71.07310Y71.0730.000
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD74.45940.785+33.674
MRQ80.36051.661+28.699
TTM98.50751.419+47.088
YOY43.63964.495-20.856
5Y71.07356.903+14.170
10Y71.07361.712+9.361
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Eris Lifesciences Ltd.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Eris Lifesciences Ltd:

  • The MRQ is 241.857. Seems overpriced? -1
  • The TTM is -1.946. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ241.857TTM-1.946+243.803
TTM-1.946YOY87.278-89.224
TTM-1.9465Y27.795-29.741
5Y27.79510Y27.7950.000
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ241.8570.015+241.842
TTM-1.9460.036-1.982
YOY87.2780.327+86.951
5Y27.7950.144+27.651
10Y27.7950.144+27.651

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Eris Lifesciences Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 4.77 means the investor is paying ₹4.77 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Eris Lifesciences Ltd:

  • The EOD is 4.419. Neutral. Compare to industry.
  • The MRQ is 4.770. Neutral. Compare to industry.
  • The TTM is 4.839. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD4.419MRQ4.770-0.350
MRQ4.770TTM4.839-0.069
TTM4.839YOY2.994+1.845
TTM4.8395Y3.917+0.922
5Y3.91710Y3.9170.000
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD4.4192.248+2.171
MRQ4.7702.690+2.080
TTM4.8393.050+1.789
YOY2.9943.185-0.191
5Y3.9172.899+1.018
10Y3.9172.711+1.206
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Eris Lifesciences Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--8.66111.042-22%126.966-93%49.683-83%49.683-83%
Book Value Growth--0.9890.9890%0.9890%0.9890%0.9890%
Book Value Per Share--149.050144.719+3%63.483+135%104.101+43%104.101+43%
Book Value Per Share Growth--0.0580.077-24%1.000-94%0.385-85%0.385-85%
Current Ratio--1.7102.426-30%2.714-37%2.570-33%2.570-33%
Debt To Asset Ratio--0.2940.227+29%0.150+96%0.188+56%0.188+56%
Debt To Equity Ratio--0.4160.303+37%0.176+135%0.240+73%0.240+73%
Dividend Per Share--7.3486.677+10%6.008+22%6.454+14%6.454+14%
Dividend Per Share Growth--0.1830.091+101%--0.091+101%0.091+101%
Eps--8.8467.377+20%4.356+103%5.866+51%5.866+51%
Eps Growth--0.332-0.071+121%1.000-67%0.286+16%0.286+16%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin--0.2610.2620%0.287-9%0.275-5%0.275-5%
Operating Margin----0%-0%-0%-0%
Operating Ratio--0.9520.933+2%0.519+84%0.726+31%0.726+31%
Pb Ratio4.419-8%4.7704.839-1%2.994+59%3.917+22%3.917+22%
Pe Ratio74.459-8%80.36098.507-18%43.639+84%71.073+13%71.073+13%
Peg Ratio--241.857-1.946+101%87.278+177%27.795+770%27.795+770%
Price Per Share658.700-8%710.900700.000+2%682.375+4%691.188+3%691.188+3%
Price To Total Gains Ratio41.145-8%44.40639.938+11%5.718+677%28.531+56%28.531+56%
Profit Growth--99.18698.693+0%99.2970%98.895+0%98.895+0%
Quick Ratio--1.0151.875-46%2.157-53%2.016-50%2.016-50%
Return On Assets--0.0420.039+9%0.047-12%0.043-3%0.043-3%
Return On Equity--0.0590.051+17%0.056+6%0.053+11%0.053+11%
Revenue Growth--0.9920.989+0%0.991+0%0.989+0%0.989+0%
Total Gains Per Share--16.00917.719-10%132.974-88%56.137-71%56.137-71%
Total Gains Per Share Growth---0.214-3.029+1318%---3.029+1318%-3.029+1318%
Usd Book Value--247286314.000240050128.000+3%201421695.000+23%220735911.500+12%220735911.500+12%
Usd Book Value Change Per Share--0.1060.135-22%1.549-93%0.606-83%0.606-83%
Usd Book Value Per Share--1.8181.766+3%0.774+135%1.270+43%1.270+43%
Usd Dividend Per Share--0.0900.081+10%0.073+22%0.079+14%0.079+14%
Usd Eps--0.1080.090+20%0.053+103%0.072+51%0.072+51%
Usd Price Per Share8.036-8%8.6738.540+2%8.325+4%8.432+3%8.432+3%
Usd Profit--14677088.00012236600.000+20%11385040.000+29%11810820.000+24%11810820.000+24%
Usd Revenue--56182220.00046753816.000+20%38910436.000+44%42832126.000+31%42832126.000+31%
Usd Total Gains Per Share--0.1950.216-10%1.622-88%0.685-71%0.685-71%
 EOD+3 -2MRQTTM+20 -14YOY+13 -195Y+17 -1710Y+17 -17

3.2. Fundamental Score

Let's check the fundamental score of Eris Lifesciences Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1574.459
Price to Book Ratio (EOD)Between0-14.419
Net Profit Margin (MRQ)Greater than00.261
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.015
Current Ratio (MRQ)Greater than11.710
Debt to Asset Ratio (MRQ)Less than10.294
Debt to Equity Ratio (MRQ)Less than10.416
Return on Equity (MRQ)Greater than0.150.059
Return on Assets (MRQ)Greater than0.050.042
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Eris Lifesciences Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose666.500
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in INR. All numbers in thousands.

Summary
Total Assets28,691,370
Total Liabilities8,422,000
Total Stockholder Equity20,269,370
 As reported
Total Liabilities 8,422,000
Total Stockholder Equity+ 20,269,370
Total Assets = 28,691,370

Assets

Total Assets28,691,370
Total Current Assets6,154,360
Long-term Assets6,154,360
Total Current Assets
Cash And Cash Equivalents 677,110
Short-term Investments 8,770
Net Receivables 2,957,140
Inventory 1,085,190
Other Current Assets 1,378,650
Total Current Assets  (as reported)6,154,360
Total Current Assets  (calculated)6,106,860
+/- 47,500
Long-term Assets
Property Plant Equipment 2,994,150
Goodwill 3,378,620
Intangible Assets 12,874,370
Other Assets 3,067,660
Long-term Assets  (as reported)22,537,010
Long-term Assets  (calculated)22,314,800
+/- 222,210

Liabilities & Shareholders' Equity

Total Current Liabilities3,598,480
Long-term Liabilities4,520,960
Total Stockholder Equity20,269,370
Total Current Liabilities
Short-term Debt 1,325,740
Short Long Term Debt 1,325,740
Accounts payable 1,165,700
Other Current Liabilities 235,510
Total Current Liabilities  (as reported)3,598,480
Total Current Liabilities  (calculated)4,052,690
+/- 454,210
Long-term Liabilities
Long term Debt Total 1,227,550
Long term Debt 834,380
Capital Lease Obligations 458,700
Long-term Liabilities Other 124,960
Long-term Liabilities  (as reported)4,520,960
Long-term Liabilities  (calculated)2,645,590
+/- 1,875,370
Total Stockholder Equity
Common Stock135,990
Retained Earnings 20,133,380
Total Stockholder Equity (as reported)20,269,370
Total Stockholder Equity (calculated)20,269,370
+/-0
Other
Capital Stock135,990
Cash and Short Term Investments 685,880
Common Stock Shares Outstanding 135,991
Liabilities and Stockholders Equity 28,691,370
Net Debt 1,483,010
Net Invested Capital 22,429,490
Net Working Capital 2,555,880



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-09-302022-03-312021-09-302021-03-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
0
0
0
0
16,846,930
18,347,800
20,517,440
22,721,390
28,691,370
28,691,37022,721,39020,517,44018,347,80016,846,9300000
   > Total Current Assets 
5,314,550
0
4,796,170
0
5,997,260
4,670,460
5,223,930
6,273,300
6,154,360
6,154,3606,273,3005,223,9304,670,4605,997,26004,796,17005,314,550
       Cash And Cash Equivalents 
0
0
0
0
0
0
426,710
508,700
677,110
677,110508,700426,710000000
       Short-term Investments 
0
0
0
0
0
982,300
1,046,330
1,670,360
8,770
8,7701,670,3601,046,330982,30000000
       Net Receivables 
1,408,280
0
2,069,080
0
1,945,890
1,404,880
1,602,120
1,609,680
2,957,140
2,957,1401,609,6801,602,1201,404,8801,945,89002,069,08001,408,280
       Inventory 
720,910
0
694,750
0
902,670
944,660
1,031,420
1,179,110
1,085,190
1,085,1901,179,1101,031,420944,660902,6700694,7500720,910
       Other Current Assets 
703,740
0
551,480
0
1,087,960
936,110
1,049,870
1,075,420
1,378,650
1,378,6501,075,4201,049,870936,1101,087,9600551,4800703,740
   > Long-term Assets 
0
0
0
0
0
0
15,293,510
16,448,090
22,537,010
22,537,01016,448,09015,293,510000000
       Property Plant Equipment 
951,040
0
872,790
0
778,680
778,780
1,404,300
1,918,570
2,994,150
2,994,1501,918,5701,404,300778,780778,6800872,7900951,040
       Goodwill 
0
0
0
0
934,740
934,740
934,740
934,740
3,378,620
3,378,620934,740934,740934,740934,7400000
       Intangible Assets 
0
0
0
0
6,907,790
6,840,760
6,691,740
6,595,980
12,874,370
12,874,3706,595,9806,691,7406,840,7606,907,7900000
       Long-term Assets Other 
0
0
0
0
0
0
48,950
243,430
372,800
372,800243,43048,950000000
> Total Liabilities 
0
0
0
0
2,667,430
2,583,590
3,261,700
3,638,280
8,422,000
8,422,0003,638,2803,261,7002,583,5902,667,4300000
   > Total Current Liabilities 
1,388,150
0
1,646,900
0
1,738,150
1,669,310
1,986,540
1,996,460
3,598,480
3,598,4801,996,4601,986,5401,669,3101,738,15001,646,90001,388,150
       Short-term Debt 
0
0
0
0
1,500
100
100
110
1,325,740
1,325,7401101001001,5000000
       Short Long Term Debt 
0
0
0
0
0
0
100
110
1,325,740
1,325,740110100000000
       Accounts payable 
729,480
0
1,000,510
0
0
0
1,167,820
1,177,740
1,165,700
1,165,7001,177,7401,167,8200001,000,5100729,480
       Other Current Liabilities 
436,400
0
306,130
0
0
0
213,630
152,370
235,510
235,510152,370213,630000306,1300436,400
   > Long-term Liabilities 
0
0
0
0
0
0
1,275,140
1,642,900
4,520,960
4,520,9601,642,9001,275,140000000
       Long term Debt Total 
0
0
0
0
0
44,470
399,730
803,940
1,227,550
1,227,550803,940399,73044,47000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-1,500
-100
443,220
393,850
-867,040
-867,040393,850443,220-100-1,5000000
       Long-term Liabilities Other 
0
0
0
0
0
0
24,650
22,820
124,960
124,96022,82024,650000000
> Total Stockholder Equity
0
0
0
0
14,179,500
15,764,210
17,255,740
19,083,110
20,269,370
20,269,37019,083,11017,255,74015,764,21014,179,5000000
   Retained Earnings 
0
0
12,797,280
0
14,043,720
15,628,430
17,119,830
18,947,180
20,133,380
20,133,38018,947,18017,119,83015,628,43014,043,720012,797,28000
   Accumulated Other Comprehensive Income 000000000
   Capital Surplus 000000000
   Treasury Stock000000000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue13,470,430
Cost of Revenue-2,663,250
Gross Profit10,807,18010,807,180
 
Operating Income (+$)
Gross Profit10,807,180
Operating Expense-9,011,060
Operating Income4,245,0401,796,120
 
Operating Expense (+$)
Research Development327,380
Selling General Administrative5,350,670
Selling And Marketing Expenses-
Operating Expense9,011,0605,678,050
 
Net Interest Income (+$)
Interest Income185,610
Interest Expense-41,460
Net Interest Income18,790144,150
 
Pretax Income (+$)
Operating Income4,245,040
Net Interest Income18,790
Other Non-Operating Income Expenses-
Income Before Tax (EBT)4,421,9804,245,040
EBIT - interestExpense = -41,460
4,061,130
4,102,590
Interest Expense41,460
Earnings Before Interest and Taxes (ebit)-4,463,440
Earnings Before Interest and Taxes (ebitda)5,110,490
 
After tax Income (+$)
Income Before Tax4,421,980
Tax Provision-364,090
Net Income From Continuing Ops4,057,8904,057,890
Net Income4,061,130
Net Income Applicable To Common Shares4,061,130
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--18,790
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
NHK.TO
1 minute ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of NHK.TO.

NHK.TO Daily Candlestick Chart
ZMU.TO
2 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ZMU.TO.

ZMU.TO Daily Candlestick Chart
PNPN.V
5 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of PNPN.V.

PNPN.V Daily Candlestick Chart
TRL.TO
5 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of TRL.TO.

TRL.TO Daily Candlestick Chart
VBNK.TO
7 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VBNK.TO.

VBNK.TO Daily Candlestick Chart
VCB.TO
9 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VCB.TO.

VCB.TO Daily Candlestick Chart
ZDH.TO
11 minutes ago

I found you a Golden Cross on the daily chart of ZDH.TO.

ZDH.TO Daily Candlestick Chart
MUS.TO
11 minutes ago

I found you a Golden Cross on the daily chart of MUS.TO.

MUS.TO Daily Candlestick Chart
VRIF.TO
13 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VRIF.TO.

VRIF.TO Daily Candlestick Chart
ZLC.TO
14 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ZLC.TO.

ZLC.TO Daily Candlestick Chart
XLY.TO
16 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of XLY.TO.

XLY.TO Daily Candlestick Chart
XGB.TO
17 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of XGB.TO.

XGB.TO Daily Candlestick Chart
XCB.TO
17 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of XCB.TO.

XCB.TO Daily Candlestick Chart
WILD.TO
18 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of WILD.TO.

WILD.TO Daily Candlestick Chart
VLNS.TO
19 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of VLNS.TO.

VLNS.TO Daily Candlestick Chart
TXG.TO
20 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TXG.TO.

TXG.TO Daily Candlestick Chart
IAF-PI.TO
23 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IAF-PI.TO.

IAF-PI.TO Daily Candlestick Chart
PNVL3.SA
28 minutes ago

I found you a Death Cross on the daily chart of PNVL3.SA.

PNVL3.SA Daily Candlestick Chart
XUTD.SW
30 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of XUTD.SW.

XUTD.SW Daily Candlestick Chart
LABB.MX
32 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of LABB.MX.

LABB.MX Daily Candlestick Chart
VGV.TO
34 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VGV.TO.

VGV.TO Daily Candlestick Chart
ZAPLOX.ST
34 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of ZAPLOX.ST.

ZAPLOX.ST Daily Candlestick Chart
WIL.V
35 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of WIL.V.

WIL.V Daily Candlestick Chart
SOZAP.ST
43 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of SOZAP.ST.

SOZAP.ST Daily Candlestick Chart
BAT.JSE
51 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of BAT.JSE.

BAT.JSE Daily Candlestick Chart